Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Vardenafil HCl.

Client Email

Product

Vardenafil HCl
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Vardenafil HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 6 USDMF, 5 CEP/COS, 2 JDMF, 8 EU WC, 2 KDMF, 13 NDC API, 21 Listed Suppliers, $ API Reference Price

27 API Suppliers
6 USDMF
5 CEP/COS
2 JDMF
8 EU WC
2 KDMF
13 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers, 32 FDA Orange Book, 39 Europe, 6 Canada, 5 South Africa, 20 Listed Dossiers

102 FDF Dossiers
32 FDA Orange Book
39 Europe
6 Canada
5 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 3 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 22 Direct Compression, 17 Thickeners and Stabilizers, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 14 Film Formers & Plasticizers, 11 Granulation, 11 Lubricants & Glidants, 11 Co-Processed Excipients, 8 Parenteral, 7 Topical, 6 Disintegrants & Superdisintegrants, 5 Empty Capsules, 5 API Stability Enhancers, 5 Solubilizers, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 2 Rheology Modifiers, 1 Soft Gelatin

45 Coating Systems & Additives
42 Fillers, Diluents & Binders
24 Controlled & Modified Release
22 Direct Compression
17 Thickeners and Stabilizers
16 Taste Masking
14 Chewable & Orodispersible Aids
14 Film Formers & Plasticizers
11 Granulation
11 Lubricants & Glidants
11 Co-Processed Excipients
8 Parenteral
7 Topical
6 Disintegrants & Superdisintegrants
5 Empty Capsules
5 API Stability Enhancers
5 Solubilizers
4 Vegetarian Capsules
4 Coloring Agents
4 Emulsifying Agents
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 26 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
26 Finished Drug Prices
2 Annual Reports

MARKET PLACE

12 APIs

12 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 5 Health Canada Patents

5 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 11 Others

2 USP
11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,164 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 4Bayer Inc.

02 1Bayer Inc., Healthcare Division

filter Patent Reset all filters

5 All

01 42309332

02 12599617

filter Product Reset all filters

5 All

01 5Vardenafil Hydrochloride

filter Dosage Reset all filters

5 All

01 2Disintegrating Tablet

02 3Tablet

filter Exp Date Reset all filters

5 All

01 42018-10-31

02 12026-02-16

US Patents
Health Canada Patents

Product Main Page

01

Bayer Inc., Healthcare Division

Vardenafil Hydrochloride

Formnext Forum

Not Confirmed

Bayer Inc., Healthcare Division

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer Inc.

Vardenafil Hydrochloride

Formnext Forum

Not Confirmed

Bayer Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer Inc.

Vardenafil Hydrochloride

Formnext Forum

Not Confirmed

Bayer Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer Inc.

Vardenafil Hydrochloride

Formnext Forum

Not Confirmed

Bayer Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer Inc.

Vardenafil Hydrochloride

Formnext Forum

Not Confirmed

Bayer Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2599617

Filing Date : 2006-02-16

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?